Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers

Detalles Bibliográficos
Autores principales: Jackson, AGA, Hill, A, Else, LJ, Back, DJ, Morley, R, Puls, R, Amin, J, Lin, E, Boffito, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112961/
http://dx.doi.org/10.1186/1758-2652-13-S4-P180
_version_ 1782205856746569728
author Jackson, AGA
Hill, A
Else, LJ
Back, DJ
Morley, R
Puls, R
Amin, J
Lin, E
Boffito, M
author_facet Jackson, AGA
Hill, A
Else, LJ
Back, DJ
Morley, R
Puls, R
Amin, J
Lin, E
Boffito, M
author_sort Jackson, AGA
collection PubMed
description
format Online
Article
Text
id pubmed-3112961
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31129612011-06-13 Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers Jackson, AGA Hill, A Else, LJ Back, DJ Morley, R Puls, R Amin, J Lin, E Boffito, M J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112961/ http://dx.doi.org/10.1186/1758-2652-13-S4-P180 Text en Copyright ©2010 Jackson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Jackson, AGA
Hill, A
Else, LJ
Back, DJ
Morley, R
Puls, R
Amin, J
Lin, E
Boffito, M
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title_full Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title_fullStr Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title_full_unstemmed Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title_short Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
title_sort pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in hiv-negative volunteers
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112961/
http://dx.doi.org/10.1186/1758-2652-13-S4-P180
work_keys_str_mv AT jacksonaga pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT hilla pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT elselj pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT backdj pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT morleyr pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT pulsr pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT aminj pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT line pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers
AT boffitom pharmacokineticsofplasmalopinavirritonavirfollowingtheadministrationof400100200150and20050mgtwicedailyinhivnegativevolunteers

Ejemplares similares